ÂÜÀòÂÒÂ×

Mr. Peter Cheng is the CEO and executive board member of Endofotonics. Prior to joining Endofotonics, Mr. Peter Cheng was the CTO of Biobot Surgical, a prostate biopsy robotic platform company, where he has successfully brought the product to market after obtaining FDA, CE, and TGA clearance. He was the CTO of ZIG Ventures Ltd.

Mr. Cheng is experienced in the management of Product Research & Development as well as Product Commercialization in a wide range of industries such as Magnetic & Optical Storage, Medical Devices, Consumer Electronics & Domestic Appliances, Wind Energy, Desalination & Waste Water Treatment. He was the VP of New Product Division for Hyflux Ltd where he drove the commercialization of ultra-filtration membrane technology. He was the former MD of Vestas Technology Singapore and as VP of Open Innovation, managed the Vestas Global Open Innovation programme. He established the R&D Innovation Centre for Philips Consumer Lifestyle in Suzhou, China.

He had served on the Economic Strategic Sub-Committee on "Growing Knowledge Capital", initiated by the Ministry of Finance, Singapore. He also served on the Scientific Advisory Board, Energy Research Institute at Nanyang Technology University Singapore.